ExploreWatchlistsPricing
  1. JP-listed companies
  2. TSUMURA & CO.
  3. Financials
  4. Pretax margin (%)

TSUMURA & CO. (4540)

Market cap
¥292.4B
P/E ratio
10.8x
Tsumura manufactures prescription and over-the-counter medicines, specializing in herbal extract powders and raw medicinal herbs across Japan, China, Laos, and the US.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
Mar 31, 202620.8-11.32%
Mar 31, 202523.4+50.50%
Mar 31, 202415.6-7.00%
Mar 31, 202316.7-16.25%
Mar 31, 202220+25.43%
Mar 31, 202115.9-0.00%
Mar 31, 202015.9-2.16%
Mar 31, 201916.3+7.23%
Mar 31, 201815.2+6.53%
Mar 31, 201714.3-17.58%
Mar 31, 201617.3-11.43%
Mar 31, 201519.5-10.25%
Mar 31, 201421.8-5.37%
Mar 31, 201323+0.84%
Mar 31, 201222.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat